Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.

The population pharmacokinetics of piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria treated with two different dosage regimens of dihydroartemisinin-piperaquine were characterized. Piperaquine pharmacokinetics in 98 Burmese and Karen patients aged 3 to 55 years wer...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Tarning, J, Ashley, E, Lindegardh, N, Stepniewska, K, Phaiphun, L, Day, N, Mcgready, R, Ashton, M, Nosten, F, White, N
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2008

Παρόμοια τεκμήρια

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
ανά: Tarning, J, κ.ά.
Έκδοση: (2007)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
ανά: Rijken, M, κ.ά.
Έκδοση: (2011)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

Efficacy and safety of dihydroartemisinin-piperaquine.
ανά: Myint, H, κ.ά.
Έκδοση: (2007)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
ανά: Ashley, E, κ.ά.
Έκδοση: (2010)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
ανά: Rijken, M, κ.ά.
Έκδοση: (2007)

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
ανά: Ashley, E, κ.ά.
Έκδοση: (2004)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
ανά: Ashley, E, κ.ά.
Έκδοση: (2010)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
ανά: Hoglund, R, κ.ά.
Έκδοση: (2012)

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
ανά: Phuc, B, κ.ά.
Έκδοση: (2017)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
ανά: Tarning, J, κ.ά.
Έκδοση: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
ανά: Tarning, J, κ.ά.
Έκδοση: (2014)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
ανά: Tarning, J, κ.ά.
Έκδοση: (2007)

A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
ανά: Ashley, E, κ.ά.
Έκδοση: (2005)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
ανά: Chotsiri, P, κ.ά.
Έκδοση: (2017)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
ανά: Bui Quang Phuc, κ.ά.
Έκδοση: (2017-04-01)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
ανά: Phyo, A, κ.ά.
Έκδοση: (2011)

Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam
ανά: Thanh, N, κ.ά.
Έκδοση: (2017)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
ανά: Zongo, I, κ.ά.
Έκδοση: (2014)

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
ανά: Tran, T, κ.ά.
Έκδοση: (2004)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
ανά: Tarning, J, κ.ά.
Έκδοση: (2008)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
ανά: Ashenafi Assefa, κ.ά.
Έκδοση: (2022-12-01)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
ανά: Mytton, O, κ.ά.
Έκδοση: (2007)

Pitfalls in estimating piperaquine elimination.
ανά: Tarning, J, κ.ά.
Έκδοση: (2005)

Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment
ανά: Leang, R, κ.ά.
Έκδοση: (2015)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
ανά: Permala, J, κ.ά.
Έκδοση: (2017)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
ανά: Ashenaf Assefa, κ.ά.
Έκδοση: (2023-04-01)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
ανά: Smithuis, F, κ.ά.
Έκδοση: (2006)

Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
ανά: Rijken, M, κ.ά.
Έκδοση: (2008)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
ανά: Issaka Zongo, κ.ά.
Έκδοση: (2014-01-01)

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
ανά: Hanboonkunupakarn, B, κ.ά.
Έκδοση: (2014)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2014)

Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients
ανά: Wanting Wu, κ.ά.
Έκδοση: (2021-02-01)

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
ανά: van Der Pluijm, R, κ.ά.
Έκδοση: (2019)

Quantification of the antimalarial piperaquine in plasma.
ανά: Tarning, J, κ.ά.
Έκδοση: (2008)